Ureteral Stents Market By Product Type (Double-J Stents {Open-End Stents, Closed-End Stents, Multi-Length Stents}, Single-J Stents), By Application (Kidney Stones, Urinary Strictures, Tumors, Post-Surgical Recovery, Others), By Material (Metallic Stents {Stainless Steel, Nitinol, Others}, Polymeric Stents {Silicone, Polyurethane, Hydrophilic Polymers}, Hybrid Stents), By Coating (Coated Stents {Hydrophilic Coating, Antibacterial Coating, Drug Coating} Non-Coated Stents), By Length (Below 20 cm, 20–24 cm, 25–28 cm, Above 28 cm), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Ureteral Stents market accounted for USD 528.3 Million in 2024 and is expected to reach USD 1,023.9 Million by 2035, growing at a CAGR of around 6.2% between 2025 and 2035. The ureteral stents market is the sphere of business related to the creation, distribution, and application of ureteral stents-catheters used to maintain the patency of the ureters and enlarged or eroded by kidney stones, tumors, or strictures of ureters, or applied for facilitating urine outflow after ureteroscopy.

Ureteral stents can be categorized into double-J and single-J stents, and the materials used for manufacturing are metal, silicone, and polyurethane. The target market is defined by growth in several areas, including advancements in medical technologies, increased awareness of urological diseases, and global trends in the rise of renal diseases.

Report Scope:

Market Dynamics

Rising Global Burden of Chronic Kidney Diseases Fuels Demand for Ureteral Stents

The high incidence of patients suffering from chronic kidney disease around the world, especially in developing nations, is another potential market driver for ureteral stents since these diseases complicate and create conditions that require stent implementation. The common causes of chronic kidney disease (CKD), aside from genetic factors, include diabetes, hypertension, an increasing elderly population, and lifestyle changes. Ureteral stents serve a dual purpose, they effectively bypass urinary obstructions and protect the kidney by maintaining the patency of the collecting system in patients with chronic kidney disease (CKD) who are at risk for postoperative complications following other surgical interventions.

According to the National Kidney Foundation, an estimated 10 percent of the global population has chronic kidney disease (CKD), with millions of patients progressing to more severe stages that require medical treatment. The large and expanding patient base and the latest innovations in stent technology have expanded the market for ureteral stents in developed and developing nations.

Growth of Ambulatory Surgery Centers Boosts Ureteral Stent Adoption Through Cost-Effective Urological Care

The increase in the number of ambulatory surgery centers is significantly driving the demand for ureteral stents, as these centers provide same-day surgery for urological procedures. ASCs, however, have the benefit of lower charges, shorter hospital stays, and faster durations of recovery and hence make the center suitable for patients who may need procedures such as stent implantation.

The growth of the minimally invasive urological service offerings has made ASCs invaluable in delivering timely services such as managing kidney stones and urinary obstructions, among other post-operative care. This trend is supported by advancements in stent technologies that enhance procedural effectiveness for outpatient procedures. These factors include convenience, cost, and effectiveness of ASCs, which consequently are raising the popularity of ureteral stents in such facilities.

Patient Non-Compliance with Follow-Up Care Hampers Ureteral Stent Market Growth

A major threat to the growth of the ureteral stents market is patient noncompliance with follow-up care, along with potential complications such as stent migration, infections, and blockages. Most patients never come back for routine checkups, which are important when ascertaining the position of the stent and whether it is functioning as expected or if the situation can get worse. Failure to deal with it can lead to long-term discomfort. The main justifications for this noncompliance include the inability to comprehend the instructions, financial considerations, and the number of visits required by the hospital. As a result, issues related to different factors that affect patient outcomes are a concern to human healthcare providers in managing outcomes when using ureteral stents, which have limited application. For this, patient education, health care access, and follow-up modification should come into play.

Integration of Smart Technologies in Ureteral Stents to Revolutionize Patient Monitoring and Care

The introduction of smart technology to ureteral stents offers a real chance to modify patient surveillance and subsequent management. Intelligent ureteral stents equipped with sensors provide information about the stent's position, urine flow rate, and potential complications, including infections and blockages. Through their monitoring capability, this technology allows a direct way of observing the condition of patients by the healthcare providers and the instant involvement in the caregiving process in case of deterioration of patient status. Furthermore, wireless communication in smart stents may minimize the need for patient visits to the hospital, which enhances patient compliance. As the trend toward value-based care and non-invasive procedures grows, smart stents have the potential to improve treatment efficacy, reduce adverse effects, and lower costs for patients, thereby creating new opportunities for the overall ureteral stent market.

Growing Focus on Pediatric Urological Care Unlocks New Market for Specialized Ureteral Stents

The increasing number of children admitted for urological procedures creates a promising opportunity for ureteral stents, as there is a growing need for pediatric-specific stent designs. Children present with specific urological disorders, including congenital anomalies, kidney stones, and obstructive uropathy that necessitate stents that are appropriate to the growth and physiology of the child. We learned that as knowledge about children’s kidneys increases and treatments improve, the requirement for specifically sized and easily implantable stents for pediatric urinary tracts is expanding.

Traditionally, adult stent designs have been used in pediatric interventions; however, the industry is now developing devices specifically designed for children to address issues such as biocompatibility and retrieval. This targets the area of pediatric care as a new market segment for ureteral stents, which creates a new, upcoming product segment.

Industry Experts Opinion

“After years of hearing from patients how bothersome and sometimes painful ureteral stents are.”

• Dr. Lee Ponsky, chair of the Department of Urology at University Hospitals.

Segment Analysis

Based on the product type, the ureteral stents market has been classified into Double-J Stents and Single-J Stents. The Double-J stents segment is the largest in the ureteral stents market due to its applications in the treatment of renal stones, strictures, and post-operative drainage. Patients choose these stents for their flexibility, biocompatibility, and the minimally invasive nature of the procedure. These stents prove effective in the long term with minimal relapses and reinterventions. The curl design is two-sided to avoid slipping and offer a smoother trip throughout the day. They do not move around or irritate. Minimally invasive urological procedures and improvements in stent technology edge Double-J stents over their competitors are on the rise.

Based on the product type, the ureteral stents market has been classified into Kidney Stones, Urinary Strictures, Tumors, Post-Surgical Recovery, and Others. The kidney stones segment holds the largest market share among all application areas because nephrolithiasis is more common worldwide, and healthcare providers effectively use ureteral stents for stone management. Ureteral stents are employed commonly for the relief of obstruction due to stones, for the passage of the rocks, and to avoid complications like hydronephrosis. More cases of kidney stones are attributable to sedentary lives, changes in diets, and dehydration conditions, and thus add to demand. Ureteroscopy and lithotripsy, which represent minimally invasive treatments, have augmented the segment’s strength.

Regional Analysis

North America has the largest ureteral stents market due to a well-developed healthcare sector, a significant number of urological disorders, and better adoption of minimally invasive surgeries. Leading vendors such as Boston Scientific, Becton Dickinson and Company, and Teleflex Inc. regularly execute product innovations, populating the market with their offerings. More young people are developing kidney-related problems, and with the increasing population of elderly people, the market for stone management is expanding.

The US dominates the region because it has shown adequate healthcare spending, appropriate reimbursement schemes, and relatively high adoption of new technologies. New product development and investment, coupled with clinical progress, provide further support to the region’s share. This is due to North America's robust regulatory systems and unwavering commitment to patient safety and outcomes.

The Asia-Pacific is the leading geographical market for the global ureteral stents market, which is expanding at a very fast rate due to growing investments in the healthcare segment, escalating incidences of urological disorders, and increasing awareness of the latest treatment procedures available for the ureteral stents. The leaders are China, India, and Japan, backed by an enlarging healthcare industry and a vulnerable aging population, which is vulnerable to disorders involving kidneys. Minimally invasive surgery is becoming popular in the region due to the availability of the latest medical technologies.

Advancements in the medical tourism industry, particularly in India and Thailand, have increased the global demand for ureteral stents. Potential causes of rapid growth include policy changes oriented to the development of healthcare systems in the region and the penetration of international market players. Moreover, increasing disposable incomes and improved healthcare services are expected to further boost the market. The Asia-Pacific region is driving significant growth in this market, which is projected to expand strongly in the coming years.

Competitive Landscape

The ureteral stents market is rapidly expanding due to the increasing prevalence of urinary system disorders, such as renal stones and urinary tract abnormalities. Some of the prominent market players are Boston Scientific, Teleflex Inc., Becton Dickinson and Company, B. Braun SE, and Olympus Corporation. New products are keeping pace, for example, Boston Scientific has the Tria Ureteral Stent that has enhanced surface technology to minimize the propensity of mineral deposition. The growth of minimally invasive surgical procedures, along with advancements in material technology, is contributing to the expansion of the market. The sector is expected to register a growth rate of CAGR of more than 6% in the future years due to increasing healthcare spending across the world. Such changes reveal the accelerating growth and competitive environment of the ureteral stent market.

Ureteral Stents Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In February 2023, Olympus Corporation, a global leader in MedTech, announced the acquisition of Taewoong Medical Co., Ltd, a South Korea-based medical device company known for its gastrointestinal (GI) metallic stents. This acquisition is aimed at enhancing Olympus' GI EndoTherapy product line and providing a more comprehensive solution to improve patient outcomes.

• In June 2022, Boston Scientific Corporation received a Bronze Edison Award in the Medical Implants category for its Tria Ureteral Stent. The award recognized the modified low-profile tri-axial stent system, which incorporates innovative surface technology designed to prevent biofilm formation and encrustation on the stent.

Report Coverage:

By Product Type

• Double-J Stents
  • Open-End Stents
  • Closed-End Stents
  • Multi-Length Stents
• Single-J Stents

By Application

• Kidney Stones
• Urinary Strictures
• Tumors
• Post-Surgical Recovery
• Others

By Material

• Metallic Stents
  • Stainless Steel
  • Nitinol
  • Others
• Polymeric Stents
  • Silicone
  • Polyurethane
  • Hydrophilic Polymers
• Hybrid Stents

By Coating

• Coated Stents
  • Hydrophilic Coating
  • Antibacterial Coating
  • Drug Coating
• Non-Coated Stents

By Length

• Below 20 cm
• 20–24 cm
• 25–28 cm
• Above 28 cm

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• B. Braun Melsungen AG
• Teleflex Incorporated
• Johnson & Johnson
• Coloplast A/S
• AngioDynamics, Inc.
• Cook Group
• UroVision
• Lepu Medical Material Co., Ltd.
• Stryker Corporation
• Conmed Corporation
• Abbott Laboratories
• Medi-Globe

Frequently Asked Questions (FAQs)